The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial

著录项

• 来源
  《Nephrology Dialysis Transplantation》 |2012年第12期|p.4445-4453|共9页
• 作者

  David W. Johnson12⇓‡ Fiona G. Brown3‡ Margaret Clarke4 Neil Boudville5 Tony J. Elias6 Marjorie W.Y. Foo7 Bernard Jones8 Hemant Kulkarni9 Robyn Langham1011 Dwarakanathan Ranganathan212 John Schollum13 Michael G. Suranyi14 Seng H. Tan151617 David Voss18 on behalf of the balANZ Trial Investigators;

  展开▼
• 作者单位

  1Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, Australia 2School of Medicine, University of Queensland, Brisbane, Australia 3Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia 4Fresenius Medical Care, Sydney, New South Wales, Australia 5School of Medicine and Pharmacology, University of Western Australia, Perth, Australia 6Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia 7Singapore General Hospital, Singapore, Singapore 8John Hunter Hospital, Newcastle, New South Wales, Australia 9Fremantle Hospital, Fremantle, Western Australia, Australia 10St Vincent's Hospital, Melbourne, Australia 11University of Melbourne, Melbourne, Australia 12Royal Brisbane;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词